Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma
出版年份 2016 全文链接
标题
Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma
作者
关键词
-
出版物
JOURNAL OF PATHOLOGY
Volume 239, Issue 2, Pages 139-151
出版商
Wiley
发表日期
2016-03-09
DOI
10.1002/path.4715
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
- (2014) James G. Carter et al. ANGIOGENESIS
- Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax
- (2014) Sandeepa M. Eswarappa et al. CELL
- Pericytes From Infantile Hemangioma Display Proangiogenic Properties and Dysregulated Angiopoietin-1
- (2013) Elisa Boscolo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages
- (2012) Serge Camelo et al. ANGIOGENESIS
- VEGFR-1 Mediates Endothelial Differentiation and Formation of Blood Vessels in a Murine Model of Infantile Hemangioma
- (2011) Elisa Boscolo et al. AMERICAN JOURNAL OF PATHOLOGY
- Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
- (2011) K. Ballmer-Hofer et al. BLOOD
- Inhibition of Delta-Like-4–Mediated Signaling Impairs Reparative Angiogenesis After Ischemia
- (2010) Ayman Al Haj Zen et al. CIRCULATION RESEARCH
- Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem Cells
- (2010) Shoshana Greenberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
- (2010) G Merdzhanova et al. ONCOGENE
- The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
- (2008) E S Rennel et al. BRITISH JOURNAL OF CANCER
- Vascular Endothelial Growth Factor (VEGF)-A165b Is a Weak In vitro Agonist for VEGF Receptor-2 Due to Lack of Coreceptor Binding and Deficient Regulation of Kinase Activity
- (2008) H. Kawamura et al. CANCER RESEARCH
- Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
- (2008) D. G. Nowak et al. JOURNAL OF CELL SCIENCE
- Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
- (2008) Masatoshi Jinnin et al. NATURE MEDICINE
- Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature
- (2008) Christine Kilcline et al. PEDIATRIC DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started